We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed Year-over-year Q1 revenues increase by 35% to $19.8 millionIncreasing 2024 revenue guidance to $83-85 million...
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering IRVINE, CA, and HERSTAL, BELGIUM – March 12, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the “Company” or...
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results 2023 revenue grew by 89% to $70.2 million; excluding GPS, revenues up 42%2023 gross margin expanded by 10.7 percentage...
MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6 Company to Host Conference Call with Live Q&A, March 6, 2024 at 4:30pm ET / 22:30 CET...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.68 | 27.6422764228 | 2.46 | 3.2 | 2.45 | 44914 | 2.78310602 | CS |
4 | 0.42 | 15.4411764706 | 2.72 | 3.2 | 2.21 | 49389 | 2.49480879 | CS |
12 | -0.32 | -9.24855491329 | 3.46 | 3.85 | 2.21 | 71761 | 2.85815835 | CS |
26 | 0.24 | 8.27586206897 | 2.9 | 4.64 | 2.21 | 67347 | 3.29118362 | CS |
52 | -0.51 | -13.9726027397 | 3.65 | 4.64 | 2.15 | 89461 | 3.42736731 | CS |
156 | -9.01 | -74.1563786008 | 12.15 | 13.17 | 2.15 | 76295 | 4.29808775 | CS |
260 | -9.01 | -74.1563786008 | 12.15 | 13.17 | 2.15 | 76295 | 4.29808775 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions